Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Novo Nordisk Denmark A/S
A/S
Active
Advertising protection
CVR 38180045
Kay Fiskers Plads 10, 2300
København S
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2016 · 9 years old
306 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Novo Nordisk Denmark A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
681M
1B
2B
3B
330M
2020
374M
2021
510M
2022
2.0B
2023
2.4B
2024
EBITDA
DKK millions
143M
107M
71M
36M
0M
37M
2020
40M
+8%
2021
52M
+30%
2022
111M
+113%
2023
114M
+3%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
330.145
373.940
509.920
2.017.346
2.367.751
Staff expenses
-238.729
-271.820
-281.181
-362.697
-450.591
EBITDA
37.403
40.071
51.992
110.782
113.771
Depreciation & amort.
-9.195
-9.840
-9.361
-9.762
-12.400
EBIT
28.208
30.232
42.630
101.020
101.371
Net financials
-200
-1.586
1.404
6.892
14.332
Profit before tax
28.008
28.645
44.034
107.912
115.703
Tax
6.730
7.240
10.486
25.914
29.574
Net profit
21.278
21.405
33.548
81.998
86.129
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
584.971
283.420
446.734
1.184.004
1.056.004
Equity
36.587
36.993
49.140
97.638
101.767
Long-term debt
18.909
4.764
20.613
29.882
28.221
Short-term debt
526.876
203.802
338.909
1.011.587
913.534
Total debt
545.785
208.566
359.522
1.041.468
941.755
Financial ratios
5-year trend
EBITDA margin
4.8%
This company
15.8%
Market median
-70% vs market
2020
2024
Equity ratio
9.6%
This company
38.2%
Market median
-75% vs market
2020
2024
Return on equity
84.6%
This company
18.4%
Market median
+360% vs market
2020
2024
Net profit margin
3.6%
This company
8.1%
Market median
-56% vs market
2020
2024
Asset turnover
2.24×
This company
1.12×
Market median
+100% vs market
2020
2024
Debt / equity
9.38×
This company
0.62×
Market median
-1413% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on Novo Nordisk Denmark A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
